Search icon
TCS, HDFCBANK, SBI Liquid Fund (G)
Global Health Ltd.

Global Health

NSE

0.00

0.00 (0.00)%

Healthcare

Mid-cap

With a market cap of ₹18.90L Cr.

Moderate Volatility
Stock is 1.13x as volatile as index
To access realtime data for Reliance Industries Ltd, and use advance features for trading Register or Login to Orca.

Subsidiaries

No Data Available

No Subsidiaries Data available

Management

1. Rahul Ranjan
Company Secretary & Compliance Officer
2. Naresh Trehan
Chairman & Managing Director
2. Naresh Trehan
Chairman & Managing Director
3. Hari Shanker Bhartia
Non Executive Independent Director
4. Praveen Mahajan
Non Executive Independent Director
5. Rajan Bharti Mittal
Non Executive Independent Director
6. Ravi Gupta
Non Executive Independent Director
7. Ravi Kant Jaipuria
Nominee Director
8. R Venkatesh
Nominee Director
9. Vikram Singh Mehta
Non Executive Independent Director
10. Sunil Sachdeva
Non Independent & Non Executive Director
11. Pankaj Prakash Sahni
Whole Time Director & Group CEO

Contact Information

Company Address

Medanta- Mediclinic, E-18, Defence Colony,
New Delhi, Delhi - 110024
www.medanta.org
info@medanta.org

Registrar

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: einward.ris@karvy.comWebsite: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001
Phone: 040 - 67162222/18003094001
Email: einward.ris@kfintech.com
Website: www.kfintech.com

Company Profile

The company was incorporated as ‘Global Health Private Limited’ on August 13, 2004 at New Delhi, India as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation by the Registrar of Companies, Delhi and Haryana at Delhi (RoC). The company was then converted into a public limited company under the Companies Act, 2013, pursuant to a special resolution passed by its Shareholders at the EGM held on July 31, 2021 and consequently, the name of the Company was changed to ‘Global Health Limited’ and a fresh certificate of incorporation dated August 11, 2021 was issued by the RoC.

The company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues amongst the players that operate in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. Under the “Medanta” brand, the company has a network of many hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital (Noida), which is under construction. The company strives to deliver advanced healthcare by establishing institutes of excellence that integrate medical care, teaching and research all while providing affordable medical services to patients.

Business area of the company

Global Health is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.

Key awards, accreditations, certifications and recognitions

Accreditations

  • 2011: 1st National Accreditation Board for Hospitals and Healthcare Providers (“NABH”) accreditation for the hospital at Gurugram
  • 2011: 1st National Accreditation Board for Testing and Calibration Laboratories accreditation for the hospital at Gurugram.
  • 2013: 1st Joint Commission International (JCI) accreditation for the hospital at Gurugram
  • 2014: 1st NABH (blood bank) accreditation for the hospital at Gurugram.
  • 2016: 1st NABH accreditation for the hospital at Indore.
  • 2018: 1st NABH accreditation for the hospital at Ranchi.
  • 2020: 1st NABH accreditation for the Medanta Institutional Ethics Committee at the hospital at Gurugram.
  • 2022: 1st NABH accreditation for the hospital at Lucknow.

Awards

  • 2020: Hospital at Gurugram ranked as the best private hospital in India by Newsweek.
  • 2021: Hospital at Gurugram featured in the top 200 global hospitals by Newsweek.
  • 2021: Hospital at Gurugram ranked as the best private hospital in India by Newsweek.
  • 2021: Hospital at Gurugram featured in the list of world’s best specialised hospitals for cardiology by Newsweek.
  • 2021: Hospital at Gurugram awarded ‘Best Multi-Speciality Hospital – National’ at ‘The Economic Times Healthcare Awards, 2021’.
  • 2021: Hospital at Gurugram ranked as the best multi-specialty private hospital in North India by The Week.
  • 2021: Hospital at Gurugram was ranked first for emergency, neurology, gynaecology, and ranked second for cardiology, gastroenterology, nephrology, oncology and urology by The Times of India’s Critical Care Study 2021.
  • 2022: Hospital at Gurguram featured in the list of world’s best specialised hospitals for cardiology and neurology by Newsweek.
  • 2022: Hospital at Gurugram featured in the top 250 global hospitals by Newsweek.
  • 2022: Hospital at Gurugram ranked as the best private hospital in India by Newsweek.
  • 2022: Hospital at Gurugram ranked as the best multi-speciality private hospital in North India and the second best private hospital in India as per Best All India Multi Speciality Hospital Ranking 2022 by Outlook and NEB Research.

Major Events:

  • 2009: Establishment and commencement of operations of Medanta – the Medicity Hospital at Gurugram.
  • 2010: Leased premises for clinic at the Indira Gandhi International Airport, New Delhi.
  • 2010: Leased premises for clinic at Defence Colony, New Delhi.
  • 2013: Anant Investments (i.e., Investor Selling Shareholder) invested in Company.
  • 2013: Leased premises for clinic at DLF Cybercity.
  • 2014: Entered into a 27-year lease for hospital at Indore.
  • 2015: Dunearn Investments (Mauritius) Pte Ltd invested in Company.
  • 2015: Entered into a 15-year lease for hospital at Ranchi.
  • 2015: GHPPL entered into a 33-year concession agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna.
  • 2016: Entered into a 90-year lease for a proposed hospital at Noida.
  • 2019: Commencement of operations of new hospital at Lucknow by MHPL.
  • 2020: Gurugram hospital outpatient department pharmacy taken in-house.
  • 2020: Launch of outpatient department at hospital at Patna by GHPPL.
  • 2021: Lucknow hospital outpatient department pharmacy taken in-house.
  • 2021: Indore hospital outpatient department pharmacy taken in-house.
  • 2021: Ranchi hospital outpatient department pharmacy taken in-house.
  • 2021: Launch of outpatient department pharmacy at south Delhi clinic.
  • 2022: Patna hospital’s inpatient department facility commenced operations.
  • 2022: Launch of Patna hospital outpatient department pharmacy.
  • 2022: Leased premises for clinic at Subhash Chowk.
Enrich money logo